[{"NetIncomeLoss_1_Q1_USD":43750000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":7150000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":297542000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-58000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-145712000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":161731000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":60000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":851000.0,"AssetsCurrent_0_Q1_USD":412134000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":14518000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":4000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":3739534.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":834000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-107000.0,"CommonStockSharesIssued_0_Q1_shares":50201758.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":317479000.0,"Assets_0_Q1_USD":422209000.0,"ShareBasedCompensation_1_Q1_USD":5191000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":2406000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"OperatingLeaseLiability_0_Q1_USD":2959000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-107000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":603000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":19911000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":3608000.0,"EarningsPerShareBasic_1_Q1_USD":0.92,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":48501697.0,"ProceedsFromStockPlans_1_Q1_USD":388000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":22006000.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"CommonStockValue_0_Q1_USD":50000.0,"OtherNonoperatingIncome_1_Q1_USD":100000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-6269000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":201000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":165585000.0,"CostsAndExpenses_1_Q1_USD":34433000.0,"RestrictedCash_0_Q1_USD":328000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":404750000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":43643000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":87271000.0,"Liabilities_0_Q1_USD":41262000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1741000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":161731000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5191000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-33531000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":47638565.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":818000.0,"LiabilitiesCurrent_0_Q1_USD":16850000.0,"AccountsPayableCurrent_0_Q1_USD":9147000.0,"NonoperatingIncomeExpense_1_Q1_USD":100154000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":87599000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":7384000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":3466000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":229000.0,"AdditionalPaidInCapital_0_Q1_USD":796532000.0,"LesseeOperatingLeaseDiscountRate_0_Q1_pure":0.1,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":388000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":5000000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":22006000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3006000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":1000.0,"ShortTermInvestments_0_Q1_USD":317479000.0,"EarningsPerShareDiluted_1_Q1_USD":0.9,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-13658000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":649000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":502000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1651000.0,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"OperatingIncomeLoss_1_Q1_USD":-34398000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":65756000.0,"InvestmentIncomeInterest_1_Q1_USD":154000.0,"PreferredStockValue_0_Q1_USD":null,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":22006000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":422209000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":553000.0,"ProfitLoss_1_Q1_USD":43750000.0,"StockholdersEquity_0_Q1_USD":380947000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":12000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":317538000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_1_Q1_USD":51842000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":35000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-415577000.0,"CommonStockSharesOutstanding_0_Q1_shares":50201758.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1316000.0,"Ticker":"RYTM","CIK":"1649904","name":"RHYTHM PHARMACEUTICALS, INC.","OfficialName":"Rhythm Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"415723429.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210503"}]